GACP-aligned herbal starting material
The buyer or a named downstream party may still need manufacturing, testing, packaging, certification or release work. That downstream path must be identified rather than implied.
Professional flower procurement
Specify the delivery stage before comparing the supply.
“GACP flower” and “EU-GMP flower” do not describe interchangeable offers. A credible screen starts with the buyer's intended use, destination, required manufacturing and release stage, current lot evidence and comparable commercial basis.
For licensed and otherwise authorized commercial operators. Not for patients or consumers. No public inventory or supplier identities appear on this page.
First decision
What exactly must the seller deliver?
The answer determines which facilities, authorizations, evidence and costs belong in the comparison.
Further processing still required
State the exact processing stage, responsible facility, planned work, expected yield, testing and rejection responsibility. A future plan is not a completed route.
Product offered at a defined GMP/release stage
Identify the licensed entities, facility scope, batch documents, certification or release status, destination and what remains for the buyer to complete.
Do not compare unlike prices. A quote for GACP material FCA origin cannot be ranked directly against a finished or released product delivered to the destination. Conversion, loss, testing, certification, freight and other unpriced items must remain visible.
Flower requirement spine
The fields that determine fit.
Product and quality
- Flower, starting material or another defined product stage
- Cannabinoid target, unit, testing basis and acceptable tolerance
- Cultivar requirements or permitted substitutes
- Irradiated, non-irradiated, treatment permitted or no preference
- Microbiology, contaminants, moisture, terpene or other specifications
- Packaging, bud/trim grade, shelf life and storage requirements
Execution and economics
- Destination and intended use
- Importer, manufacturer, processor and release responsibilities
- Current lot quantity, MOQ, cadence and need date
- Samples, quality review and purchasing decision process
- Currency, unit, Incoterm, named place and quote validity
- Known included costs and remaining unknowns
Lot-level screen
What “available” needs to mean.
A cultivar deck, forecast or historical COA is not current, executable supply. A buyer-ready record should support the following questions.
| Question | Useful evidence | Do not substitute |
|---|---|---|
| Which lot is being offered? | Stable lot/batch identifier and an availability confirmation date | Generic cultivar profile |
| How much is unallocated? | Total quantity, already allocated quantity, offerable kg and MOQ | Annual cultivation capacity |
| Does testing relate to that lot? | Report ID, dates, lab/method and lot linkage | Representative or historical COA without clear linkage |
| What is the commercial basis? | Price, currency, unit, Incoterm, named place, validity and inclusions | A number without delivery stage or terms |
| What route is actually supported? | Named entities, roles, authorizations and current scope evidence | “EU-GMP pathway available” without a defined party and scope |
Provenance screen
A small comparison with gaps left visible.
Mandatory failures are excluded. Unknowns request evidence; they are not converted into passes. Supplier payment does not determine recommendation priority.
Fit
Each candidate is marked pass, fail or unknown against the buyer's latest stated mandatory criteria.
Evidence
Registry checks, reviewed documents, counterparty statements and stale or missing items are distinguished and dated.
Next decision
The output names the single next evidence request or purchasing choice needed before controlled diligence can advance.
Primary sources
Standards must be applied to the real product and route.
- EMA: GACP for starting materials of herbal origin — addresses cultivation, collection and primary processing of medicinal plants and herbal substances.
- European Commission: EudraLex Volume 4 — official EU GMP guidance and annexes.
- EudraGMDP — check current manufacturing/import authorization and GMP certificate records, including scope and non-compliance statements.
Operational note: this page explains procurement questions, not a universal regulatory route. The licensed importer, manufacturer, responsible quality professionals and relevant authorities determine the requirements for the actual product and transaction.
Related
Build the rest of the decision.
Current need
Submit the product stage you actually need.
Include the destination, delivery stage, quantity, timing and non-negotiable specifications. Approximate ranges are fine for the first screen.